| dc.contributor.author | López Soto, Alejandro | |
| dc.contributor.author | González Rodríguez, Segundo | |
| dc.contributor.author | Galluzzi, Lorenzo | |
| dc.date.accessioned | 2018-02-28T10:41:35Z | |
| dc.date.available | 2018-02-28T10:41:35Z | |
| dc.date.issued | 2017 | |
| dc.identifier.citation | Oncoimmunology, 6(10), (2017); doi:10.1080/2162402X.2017.1346766 | |
| dc.identifier.issn | 2162-402X | |
| dc.identifier.uri | http://hdl.handle.net/10651/46347 | |
| dc.description.sponsorship | ALS and SG are supported by Spanish Instituto de Salud Carlos III (FIS PI16/01485). LG is supported by an intramural startup from the Department of Radiation Oncology of Weill Cornell Medical College (New York, US), and by Sotio a.c. (Prague, Czech Republic). | |
| dc.language.iso | eng | |
| dc.relation.ispartof | Oncoimmunology, 6 | |
| dc.rights | ©, | |
| dc.source | WOS:000414520200016 | |
| dc.title | Soluble NKG2D ligands limit the efficacy of immune checkpoint blockade | |
| dc.type | journal article | |
| dc.identifier.doi | 10.1080/2162402X.2017.1346766 | |
| dc.relation.projectID | ISCIII/ FIS PI16/01485 | |
| dc.relation.publisherversion | http://dx.doi.org/10.1080/2162402X.2017.1346766 | |
